CME Group Inc CME reported better-than-expected earnings for the third quarter.
CME Group reported quarterly revenue of $1.338 billion, slightly missing the consensus of $1.342 billion. Adjusted EPS of $2.25 surpassed the estimate of $2.22.
CME Group shares rose 0.9% to trade at $216.03 on Thursday.
These analysts made changes to their price targets on CME Group following earnings announcement.
- Barclays cut the price target on CME Group from $247 to $244. Barclays analyst Jeremy Campbell maintained an Overweight rating.
- Rosenblatt raised the price target on CME Group from $173 to $180. Rosenblatt analyst Andrew Bond maintained a Sell rating on the stock.
- Morgan Stanley lifted the price target on CME Group from $215 to $220. Morgan Stanley analyst Mike Cyprys maintained an Equal-Weight rating.
Also Check This Out: Kimberly-Clark, Roblox And 2 Other Stocks Insiders Are Selling
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in